About this FactMed analysis covering adverse side effect reports of BISOCARD (BISOPROLOL) patients who developed URINARY INCONTINENCE.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking BISOCARD (BISOPROLOL) reported URINARY INCONTINENCE to the FDA. A total of 10 BISOCARD (BISOPROLOL) drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between BISOCARD (BISOPROLOL) and URINARY INCONTINENCE. In doing so, we compare BISOCARD (BISOPROLOL) with other drugs that cause URINARY INCONTINENCE, to help you evaluate whether or not BISOCARD (BISOPROLOL) causes URINARY INCONTINENCE. Likewise, this page shows the most highly-reported side effects of BISOCARD (BISOPROLOL), so you can see if URINARY INCONTINENCE ranks among BISOCARD (BISOPROLOL)'s most well-known side effects.
Summary Statistics
Reports of BISOCARD (BISOPROLOL) causing URINARY INCONTINENCE: 1
Reports of any side effect of BISOCARD (BISOPROLOL) : 10
Percentage of BISOCARD (BISOPROLOL) patients where URINARY INCONTINENCE is a reported side effect: 10.0000%

FDA reports of any drug causing URINARY INCONTINENCE : 11193
Average percentage for all medicated patients where URINARY INCONTINENCE is reported as a complication: 0.0702%

Physician opinion on BISOCARD (BISOPROLOL) as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing BISOCARD (BISOPROLOL):
( 0 patients )
Drugs with high FDA adverse event association with URINARY INCONTINENCE:

FOSAMAX (2180 patients)
AVONEX (1018 patients)
ASPIRIN (941 patients)
TYSABRI (732 patients)
VIOXX (694 patients)
ZOMETA (577 patients)
LISINOPRIL (525 patients)
LYRICA (496 patients)
LIPITOR (467 patients)
NEURONTIN (451 patients)
SYNTHROID (436 patients)
SEROQUEL (422 patients)
LASIX (396 patients)
PREDNISONE (395 patients)
PREMARIN (381 patients)
ATENOLOL (379 patients)
ZOLOFT (359 patients)
NEXIUM (357 patients)
CLOZARIL (355 patients)
XANAX (351 patients)
PRILOSEC (345 patients)
COUMADIN (342 patients)
REBIF (335 patients)
CYMBALTA (330 patients)
PROTONIX (322 patients)
SIMVASTATIN (313 patients)
CELEBREX (313 patients)
HYDROCHLOROTHIAZIDE (313 patients)
AMBIEN (303 patients)
FUROSEMIDE (302 patients)
OMEPRAZOLE (295 patients)
ALENDRONATE SODIUM (294 patients)
DEXAMETHASONE (292 patients)
LEXAPRO (282 patients)
ZYPREXA (281 patients)
GABAPENTIN (280 patients)
AREDIA (276 patients)
LORAZEPAM (268 patients)
DETROL LA (267 patients)
DIGOXIN (265 patients)
ACETAMINOPHEN (263 patients)
NORVASC (263 patients)
BACLOFEN (257 patients)
DURAGESIC-100 (255 patients)
PAXIL (254 patients)
METHOTREXATE (250 patients)
FORTEO (248 patients)
LEVOTHYROXINE SODIUM (246 patients)
VITAMIN D (246 patients)
RISPERDAL (245 patients)
OXYCONTIN (244 patients)
PERCOCET (242 patients)
ALBUTEROL (242 patients)
POTASSIUM CHLORIDE (242 patients)
NAMENDA (241 patients)
ZOCOR (239 patients)
BETASERON (230 patients)
FLOMAX (228 patients)
LEVAQUIN (220 patients)
VICODIN (213 patients)
DIAZEPAM (212 patients)
PROZAC (210 patients)
FOSAMAX PLUS D (207 patients)
ATIVAN (206 patients)
FOLIC ACID (206 patients)
DIOVAN (205 patients)
DEPAKOTE (204 patients)
CLONAZEPAM (203 patients)
ALPRAZOLAM (195 patients)
PLAVIX (194 patients)
RISPERIDONE (190 patients)
EFFEXOR (189 patients)
TOPROL-XL (188 patients)
ZOFRAN (185 patients)
REMICADE (184 patients)
HUMIRA (176 patients)
IBUPROFEN (174 patients)
PREVACID (173 patients)
MULTI-VITAMINS (172 patients)
ARICEPT (172 patients)
KLONOPIN (171 patients)
ABILIFY (170 patients)
REGLAN (169 patients)
CALCIUM (168 patients)
PREDNISONE TAB (167 patients)
MIRALAX (167 patients)
DECADRON (166 patients)
TRAZODONE HCL (166 patients)
ALLOPURINOL (163 patients)
CRESTOR (162 patients)
WELLBUTRIN (162 patients)
ZANTAC (161 patients)
DETROL (160 patients)
ENBREL (160 patients)
SPIRIVA (159 patients)
MORPHINE (156 patients)
TOVIAZ (153 patients)
TAMOXIFEN CITRATE (152 patients)
VITAMIN E (151 patients)
WARFARIN SODIUM (151 patients)
AMLODIPINE (149 patients)
AMOXICILLIN (148 patients)
CALCIUM (UNSPECIFIED) (146 patients)
ZYRTEC (146 patients)
OXYCODONE HCL (146 patients)
ADVAIR DISKUS 100/50 (145 patients)
METFORMIN HCL (144 patients)
EXELON (143 patients)
STROMECTOL (142 patients)
LOPRESSOR (142 patients)
EFFEXOR XR (137 patients)
MORPHINE SULFATE (136 patients)
COZAAR (135 patients)
METOPROLOL TARTRATE (132 patients)
CLOZAPINE (132 patients)
VALIUM (131 patients)
TRAMADOL HCL (129 patients)
INSULIN (128 patients)
TEMAZEPAM (126 patients)
SANDOSTATIN LAR (126 patients)
ASCORBIC ACID (125 patients)
NITROGLYCERIN (125 patients)
CLINDAMYCIN (125 patients)
METOCLOPRAMIDE (124 patients)
SOLU-MEDROL (124 patients)
LOVENOX (124 patients)
SINGULAIR (124 patients)
TEGRETOL (123 patients)
VITAMINS (UNSPECIFIED) (123 patients)
KEFLEX (122 patients)
FENTANYL (122 patients)
VESICARE (120 patients)
CELEXA (120 patients)
BONIVA (119 patients)
ULTRAM (119 patients)
CITALOPRAM HYDROBROMIDE (117 patients)
ENALAPRIL MALEATE (117 patients)
RADIATION THERAPY (116 patients)
ELAVIL (115 patients)
PREDNISOLONE (114 patients)
KEPPRA (113 patients)
FLEXERIL (113 patients)
CIPROFLOXACIN (113 patients)
VINCRISTINE (113 patients)
ALTACE (111 patients)
VALPROATE SODIUM (111 patients)
ACTONEL (111 patients)
LORTAB (110 patients)
ALLEGRA (110 patients)
ARANESP (110 patients)
EVISTA (108 patients)
CLONIDINE (108 patients)
VITAMIN D (UNSPECIFIED) (107 patients)
NAPROXEN (107 patients)
BENADRYL (105 patients)
MULTI-VITAMIN (105 patients)
ZITHROMAX (105 patients)
PEPCID (104 patients)
TOPAMAX (102 patients)
OLANZAPINE (101 patients)
SOMA (101 patients)
LOSARTAN POTASSIUM (100 patients)
FEMARA (99 patients)
VANCOMYCIN (99 patients)
LANTUS (98 patients)
CALCIUM CARBONATE (98 patients)
KYTRIL (97 patients)
COLACE (97 patients)
VITAMIN B-12 (96 patients)
RAMIPRIL (94 patients)
ZANAFLEX (94 patients)
FLUOXETINE (94 patients)
TAXOTERE (93 patients)
SPIRONOLACTONE (93 patients)
CARBAMAZEPINE (92 patients)
COREG (92 patients)
CYCLOPHOSPHAMIDE (91 patients)
ACTOS (91 patients)
CASODEX (90 patients)
GLUCOPHAGE (89 patients)
ACIPHEX (89 patients)
BACTRIM (89 patients)
RESTORIL (88 patients)
METHYLPREDNISOLONE (87 patients)
METOPROLOL (87 patients)
CLARITIN (86 patients)
PREMPRO (86 patients)
CEPHALEXIN (85 patients)
LUPRON (85 patients)
MOBIC (85 patients)
DIFLUCAN (85 patients)
DILAUDID (84 patients)
PANTOPRAZOLE (84 patients)
LIORESAL (83 patients)
CHANTIX (83 patients)
HEPARIN (83 patients)
REVLIMID (82 patients)
AUGMENTIN '125' (82 patients)
TYLENOL (CAPLET) (82 patients)
VERAPAMIL (82 patients)
MIRTAZAPINE (82 patients)
POTASSIUM (82 patients)
AVELOX (82 patients)
ENABLEX (82 patients)
FERROUS SULFATE TAB (81 patients)
DEPAKENE (80 patients)
GLIPIZIDE (80 patients)
GLYBURIDE (79 patients)
LAMICTAL (79 patients)
LACTULOSE (79 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for BISOCARD (BISOPROLOL)


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about URINARY INCONTINENCE and BISOCARD (BISOPROLOL), post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking BISOCARD (BISOPROLOL), post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in BISOCARD (BISOPROLOL). This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for BISOCARD (BISOPROLOL) experts. If you are a healthcare provider experienced in prescribing BISOCARD (BISOPROLOL), please register here.
© 2014 FactMed, Inc
Privacy Policy
Terms of Use